Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Synageva BioPharma Corp Company Profile (NASDAQ:GEVA)

Consensus Ratings for Synageva BioPharma Corp (NASDAQ:GEVA) (?)
Ratings Breakdown: 3 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $109.11 (57.45% upside)

Analysts' Ratings History for Synageva BioPharma Corp (NASDAQ:GEVA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/1/2014Janney Montgomery ScottReiterated RatingFair Value$107.00 -> $111.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2014JPMorgan Chase & Co.Reiterated RatingOverweight$115.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2014Citigroup Inc.Initiated CoverageNeutral$113.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Leerink SwannReiterated RatingMarket Perform$101.00 -> $89.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2014NomuraLower Price TargetBuy$144.00 -> $140.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2014Janney Montgomery ScottUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
4/8/2014WedbushUpgradeNeutral -> Outperform$93.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014Morgan StanleyReiterated RatingOverweight$118.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Janney Montgomery ScottReiterated RatingFair Value$52.00 -> $107.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014NomuraBoost Price Target$112.00 -> $144.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Leerink SwannBoost Price Target$62.00 -> $101.00ViewTweet This Rating  Share This Rating on StockTwits
2/14/2014Canaccord GenuityBoost Price TargetBuy$105.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014JPMorgan Chase & Co.UpgradeNeutral -> Overweight$60.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2014Goldman SachsReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/16/2014Canaccord GenuityBoost Price TargetBuy$72.00 -> $105.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014NomuraInitiated CoverageBuy$85.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Robert W. BairdInitiated CoverageOutperform$83.00ViewTweet This Rating  Share This Rating on StockTwits
11/14/2013Goldman SachsInitiated CoverageBuy$72.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Canaccord GenuityBoost Price TargetBuy$60.00 -> $72.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Leerink SwannDowngradeOutperform -> Market Perform$66.00 -> $62.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013WedbushDowngradeOutperform -> Neutral$55.00 -> $67.00ViewTweet This Rating  Share This Rating on StockTwits
5/10/2013JPMorgan Chase & Co.DowngradeNeutral$50.00ViewTweet This Rating  Share This Rating on StockTwits
5/10/2013JPMorgan Chase & Co.DowngradeOverweight -> Neutral$57.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013WedbushBoost Price Target$53.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013Piper JaffrayReiterated RatingNeutral$53.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013Leerink SwannBoost Price TargetOutperform$55.00 -> $66.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageNeutral$52.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Piper JaffrayDowngradeOverweight -> Neutral$66.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Janney Montgomery ScottInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
11/7/2012WedbushBoost Price TargetOutperform$42.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2012Piper JaffrayInitiated CoverageOverweight$66.00ViewTweet This Rating  Share This Rating on StockTwits
8/3/2012Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2012 forward)